Moreover, the percentage of MLL-r AML cells at G0/G1 phase increased, accompanied by a marked decrease in S and G2/M phases after loss of EP300 or CREBBP (Fig. 2D). This evidence concerns the gene KMT2A and acute myeloid leukemia.